海外市场拓展
Search documents
1月批售32.7万辆,上汽集团销量同比增长23.9%
Jing Ji Guan Cha Wang· 2026-02-02 07:19
Core Viewpoint - SAIC Motor Corporation reported strong sales performance in January 2026, with both wholesale and retail figures showing significant year-on-year growth, indicating a continued recovery trend from the previous year [1] Sales Performance - In January, SAIC's wholesale vehicle sales reached 327,000 units, representing a year-on-year increase of 23.9% [1] - The retail sales totaled 363,000 units, maintaining a leading position in the industry [1] Segment Analysis - The sales of SAIC's self-owned brands amounted to 214,000 units, up 39.6% year-on-year, increasing their share of total sales to 65.3%, a rise of 7.3 percentage points compared to the same period last year [1] - SAIC Passenger Vehicle sales were 77,000 units, showing a year-on-year growth of 53.8% [1] - SAIC Maxus sales reached 18,000 units, with an 18.2% increase year-on-year [1] - SAIC-GM-Wuling sales were 105,000 units, reflecting a year-on-year growth of 37% [1] New Energy Vehicle Expansion - SAIC's new energy vehicle sales in January reached 85,000 units, marking a year-on-year increase of 39.7% [1] - Among these, SAIC Passenger Vehicle new energy sales were 28,000 units, showing significant growth [1] - SAIC-GM new energy sales were 6,000 units, with an increase of over 300% year-on-year [1] - SAIC-GM-Wuling new energy sales reached 36,000 units, becoming a crucial part of the group's new energy segment [1] Overseas Market Growth - SAIC's overseas sales in January totaled 105,000 units, reflecting a year-on-year growth of 51.7% [1] - The MG brand delivered nearly 26,000 units in the European market in January, achieving a year-on-year growth of approximately 15% [1] - The overseas business has increasingly contributed to the overall sales performance of the group [1]
科兴制药:2025年预计净利润1.35亿元至1.75亿元,实现了海外收入的强劲增长
Cai Jing Wang· 2026-02-02 05:11
近日,科兴制药发布公告称,预计2025年年度实现归母净利润为1.35亿元至1.75亿元,同比增加 328.83%至455.89%,预计归母净利润扣除非经常性损益后为5000万元至7000万元,同比增加41.83%至 98.56%。 (编辑:杨燕 林辰)关键字: 医疗 (科兴制药公告) 本期业绩变化的主要原因是公司积极开拓海外市场,实现了海外收入的强劲增长,推动营业收入持续增 长。报告期内,非经常性损益金额较上年同期变动主要系公司持有的私募基金公允价值变动及处置下属 子公司所致。 ...
新希望20260130
2026-02-02 02:22
新希望 20260130 摘要 新希望六和 2025 年因资产清理和减值计提导致亏损,其中 60%以上为 一次性影响,主要为提前处置低效种猪以提升种猪质量,为 2027 年战 略做准备。 饲料业务在 2025 年达到历史最高销量,实现量利双增,国内外市场均 有改善,海外市场保持高速增长,经营性现金流稳定在 92 亿元左右, 吨完全费用同比降低 30 元。 生猪养殖通过健康管理(降低非洲猪瘟发病率,净化伪狂犬病)、生产 管理(提高母猪窝均断奶数,提高育肥效率)和育种改良(引进国外优 质精液)等措施降低成本,运营成本降至 12.2 元/公斤。 2026 年,新希望六和将坚持现有战略,饲料业务上规模、调结构、提 效率,提高单场满负荷率,加强预混料外部市场开发,海外市场提升产 能利用率,并加强海外人才储备。 2026 年生猪养殖目标是每公斤成本降低 1-1.5 元,饲料完全费用再降 20 元,通过种质资源优化、提高养殖效率、减少过程损耗等多方面实现 综合成本下降。 Q&A 请介绍一下新希望六和在 2025 年的业绩表现及主要原因。 新希望六和在 2025 年预计亏损 15 至 18 亿元,同比转亏。主要原因是第四季 ...
安靠智电20260201
2026-02-02 02:22
安靠智电 20260201 摘要 安靠智电 2025 年坏账计提约 8,000 万元,主要受地方政府平台公司履 约问题影响,涉及张家港南横套项目和溧阳等地工程,同时,公司在特 高压电缆附件等核心业务板块的前瞻性技术研发投入较大,导致研发费 用增长。 公司变压器板块正执行中国绿发新疆若羌和浠水变电站项目,价值近 2 亿元,预计 2026 年上半年确认收入。中标巴基斯坦四个变电站项目, 价值 7,000 多万元,并计划参与绿发在新疆、青海等地新建站点的招标, 预计总价值 4-5 亿元。 北美市场方面,安靠智电跟踪订单总额约 5,000 万美元,包括数据中心 油浸式变压器订单(890 万美元)和北美某州水电公司的 230kV 变压 器框采协议。南美市场主要集中在巴西、哥伦比亚和委内瑞拉,已有部 分订单落地。 公司计划继续加大核心业务板块的研发投入,拓展海外市场,通过获取 北美数据中心、电力公司及南美国家的大额订单来提升国际业务占比。 为满足出海需求,公司将持续扩充研发生产人员,并取得相关认证。 Q&A 请介绍一下安靠智电 2025 年的业绩预告情况及四季度的减值计提原因。 2025 年,安靠智电的业绩预告显示整体业 ...
实力铸就16连冠!“中国造”船舶扬帆出海
Yang Shi Xin Wen Ke Hu Duan· 2026-02-02 00:39
2025年,我国造船业再次交出亮眼成绩单:造船完工量、新接订单量、手持订单量三大核心指标连续16年稳居全球第一,市场份额均超半数。与此同时, 全球领先LNG运输船"天山"号顺利交付、福建滚装船出口印尼实现"开门红",标志着我国在高技术船舶自主研发与海外市场拓展方面取得双重突破。 连续16年世界第一! 2025年我国造船业三大指标继续领跑全球 2月1日,工业和信息化部发布我国造船业最新数据。2025年,我国造船业三大指标继续领跑全球,连续16年保持世界第一。 最新数据显示,2025年我国造船完工量5369万载重吨,同比增长11.4%,占全球市场总量的56.1%;新接订单量10782万载重吨,占全球市场总量的69%; 截至12月末,手持订单量27442万载重吨,同比增长31.5%,占全球市场总量的66.8%,手持订单量再创历史新高。 不仅三大造船指标继续全球领跑,2025年,我国骨干船企国际竞争力不断增强,分别有6家企业位居世界造船完工量、新接订单量和手持订单量前10强。 18种主要船型中有16种船型新接订单量位居世界第一,多型世界级绿色智能船舶交付,高端转型取得重要突破,行业高质量发展取得了明显成绩。 自主研发 ...
东鹏饮料(605499):跟踪点评:结盟三林集团,海外乘风启航
Changjiang Securities· 2026-02-01 23:30
Investment Rating - The investment rating for the company is "Buy" and is maintained [8] Core Insights - The company has completed registration procedures in Indonesia and obtained necessary overseas investment permits. It has partnered with "RICH STREAM INVESTMENT PTE. LTD." to invest up to $300 million in the Indonesian market for functional beverages, factory construction, and related business [2][6] - The partnership with RICH STREAM INVESTMENT PTE. LTD. is expected to accelerate the company's expansion into Southeast Asia, leveraging the extensive distribution channels of the Indonesian partner, which includes 23,000 stores [13] - The company plans to invest 1.1 billion yuan in the Chengdu production base to optimize its supply chain and enhance production capacity, which is projected to exceed 4.8 million tons per year by 2024 [13] - The company is enhancing its product launch capabilities and internal management, with expectations for significant revenue contributions from new product lines such as bottled water, milk tea, and fruit tea. EPS forecasts for 2025, 2026, and 2027 are 8.56, 10.61, and 12.71 yuan, respectively, with corresponding PE ratios of 29X, 24X, and 20X [13] Financial Summary - Total revenue projections are 15.839 billion yuan for 2024, increasing to 31.166 billion yuan by 2027. Operating profit is expected to rise from 4.145 billion yuan in 2024 to 8.288 billion yuan in 2027 [20] - The net profit forecast for 2024 is 3.326 billion yuan, growing to 6.610 billion yuan by 2027, with EPS increasing from 6.40 yuan to 12.71 yuan over the same period [20]
中际联合(605305):年报预告符合预期,2025年归母净利润同比增长59%-75%
ZHESHANG SECURITIES· 2026-02-01 12:32
Investment Rating - The investment rating for the company is "Buy" [4] Core Views - The company is expected to achieve a significant increase in net profit for 2025, with a forecasted growth of 59%-75%, translating to a net profit of between 500 million to 550 million yuan [1][2] - The growth is driven by the rapid expansion of the wind power industry, improved order structure, and enhanced customer recognition of the company's products [2] - The company is positioned as a leader in high-altitude safety equipment for wind power, benefiting from both domestic market demand and overseas expansion opportunities [2][3] Financial Summary - The projected net profit for 2025 is approximately 521 million yuan, with a year-on-year growth of 66% [5] - Revenue is expected to reach 1.845 billion yuan in 2025, reflecting a 42% increase [5] - The earnings per share (EPS) for 2025 is estimated at 2.45 yuan, with a price-to-earnings (P/E) ratio of 18 [5] Growth Drivers - The company is enhancing its product offerings in response to customer needs, leading to an increase in order size and value [2] - The domestic wind power market is projected to maintain high demand, with new installations expected to reach at least 120 GW during the 14th Five-Year Plan [2] - The company is also expanding into multiple sectors, including industrial and construction, emergency rescue, and power grid applications, which are expected to contribute to future growth [3]
药企密集发布业绩预告:海外市场助推业绩 多家打赢“翻身仗”
Bei Ke Cai Jing· 2026-01-31 12:37
百余家医药企业发布业绩预告 19家年内实现业绩翻身 1月30日,新京报贝壳财经记者根据Wind数据整理发现,474家医药企业中,255家已发布2025年业绩预告。81家企业释放出积极信号,其中,50家企业出现 业绩预增,6家业绩略增。 | 业绩预告类型 | 数量 | | --- | --- | | 不确定 | 1 | | 略減 | 3 | | 略增 | 6 | | 扭亏 | 24 | | 首亏 | 38 | | 续亏 | 90 | | 续盈 | 1 | | 预减 | 42 | | 预增 | 50 | | 总数 | 255 | 近日,A股医药板块上市公司开始密集披露2025年度业绩预告。据新京报贝壳财经统计,截至1月30日,已有255家相关企业公布了业绩预告数据。 其中超三成企业释放积极信号——50家业绩预增、24家实现扭亏,打赢"翻身仗",化学制药、医疗器械、医疗服务等领域企业表现突出。 值得注意的是,海外市场成为多家企业增长的共同引擎。以理邦仪器为例,公司在业绩预告中强调"国际市场保持两位数增长"。与此同时,部分企业通过降 本增效、产品结构调整成功实现业绩逆转。 行业内部亦呈现结构性分化,从2025年业绩表 ...
新 希 望(000876) - 2026年01月30日投资者关系活动记录表
2026-01-31 12:32
Group 1: Financial Performance and Forecast - The company anticipates a net loss of 1.5 to 1.8 billion RMB for 2025, influenced by industry adjustments and one-time impacts [2] - The operational cash flow for 2025 is expected to remain stable at over 9 billion RMB, primarily due to the recovery in the feed business [3] Group 2: Feed Business Strategy - The company aims to reduce costs and improve efficiency in the feed business, achieving a decrease of 30 RMB per ton in 2025 compared to 2024 [4] - A target of increasing feed sales by approximately 3 million tons in 2026, maintaining double-digit growth [4] Group 3: Swine Breeding and Cost Reduction - The cost reduction target for swine breeding in 2026 is set at 1 to 1.5 RMB per kilogram, focusing on health management and production efficiency [5] - The average cost of breeding stock has decreased to below 2.6 RMB per kilogram in 2025, down by 0.6 RMB year-on-year [6] Group 4: Capital and Financing - The company maintains a strong liquidity position, with banks showing positive support for financing, reflected in the lowest interest rates in the agricultural sector [5] - The company is actively working on a private placement with a revised fundraising scale of 3.338 billion RMB [7] Group 5: International Expansion - The company aims to achieve a target of 10 million tons in overseas feed business by around 2030, with a short-term goal of over 1 million tons growth in 2026 [8] - Focus on increasing market share in 14 key countries, including Vietnam and Indonesia, where the company is already among the top five [8]
唐宁街10号官宣:泡泡玛特欧洲总部将设在伦敦
Xin Lang Cai Jing· 2026-01-31 08:11
"英国首相八年来首次访华,圆满结束访问,"声明提到,斯塔默此次中国之行,"达成22亿英镑的出口 协议,获得约23亿英镑的市场准入,并锁定数亿英镑的投资"。 声明举例提到,英国威士忌对华出口关税从10%降至5%,以及泡泡玛特、奇瑞、海能技术、阿斯利康 等多个投资案例。声明称,这表明,与中国建立务实、清醒的关系具有明显的经济效益。 根据声明公布消息,泡泡玛特已确认将伦敦设立为欧洲区域中心。该公司计划在未来一年内开设27家欧 洲新店,其中包括至多7家英国门店,预计将为英国创造超过150个就业岗位。 此外,奇瑞确认将在英国城市利物浦设立欧洲总部。 【文/观察者网 齐倩】 中国潮玩品牌泡泡玛特决定将欧洲区域总部设在英国伦敦。 1月31日,英国首相斯塔默办公室唐宁街10号发布声明,宣布了这一消息。 30日,斯塔默在上海接 受采访 视频截图 彭博社提到,在英国设立区域总部,体现了泡泡玛特在欧洲市场的雄心壮志。 泡泡玛特公司预计,2025年上半年,欧洲市场的收入占比不到3.4%,而美洲市场则高达16.3%。但去年 起,随着玩偶"拉布布"风靡全球,该公司在欧洲市场实现了快速增长。 近来,泡泡玛特一直在欧洲各地招募艺术家,根据当 ...